Erfindungsgemäß wird ein Arzneimittel zur oralen Verabreichung des Wirkstoffs Galanthamin zur Verfügung gestellt, umfassend Pellets und mindestens eine Tablette, wobei die Pellets einen inerten Kern und mindestens eine wirkstoffhaltige Beschichtung aufweisen, die den Wirkstoff verzögert freisetzt und die Tablette den Wirkstoff schnell freisetzt.Medicament for the oral administration of galantamine or its salt, comprises pellets and at least one tablet, where the pellets having an inert core and at least one active substance containing coating, which releases the active substance in a sustained manner and the tablet rapidly releases the active substance. An independent claim is included for manufacturing the medicament comprising producing pellets, in which an inert core is provided with at least one active substance containing coating, producing at least one rapid release active substance containing tablet and combining the pellets with the tablet. ACTIVITY : Neuroprotective Nootropic. No biological data given. MECHANISM OF ACTION : None given.
